LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

Search

Omnicell Inc

Slēgts

SektorsVeselības aprūpe

32.56 -2.22

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

32.44

Max

32.68

Galvenie mērījumi

By Trading Economics

Ienākumi

13M

5.6M

Pārdošana

21M

291M

P/E

Sektora vidējais

66.18

35.724

EPS

-0.151

Peļņas marža

1.941

Darbinieki

3,650

EBITDA

42M

30M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+28.11% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 29. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

162M

1.5B

Iepriekšējā atvēršanas cena

34.78

Iepriekšējā slēgšanas cena

32.56

Ziņu noskaņojums

By Acuity

15%

85%

18 / 371 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bearish Evidence

Omnicell Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 29. aug. 18:43 UTC

Galvenie tirgus virzītāji

Privia Health Shares Advance on Outlook Bump From Medicare Savings

2025. g. 29. aug. 15:07 UTC

Iegādes, apvienošanās, pārņemšana

Strathcona Resources to Increase Minority Stake in MEG Energy, Vote Against Cenovus Buyout Plan

2025. g. 30. aug. 08:20 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Auto & Transport Roundup: Market Talk

2025. g. 29. aug. 20:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Auto & Transport Roundup: Market Talk

2025. g. 29. aug. 20:24 UTC

Peļņas

Earnings Season Highlights on Tariffs, Consumer Spending, and More -- Barrons.com

2025. g. 29. aug. 20:17 UTC

Peļņas

These Stocks Moved the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

2025. g. 29. aug. 19:18 UTC

Tirgus saruna

Oil Futures End Week With Modest Gains -- Market Talk

2025. g. 29. aug. 18:59 UTC

Tirgus saruna

U.S. Natural Gas Futures Post Weekly Gains -- Market Talk

2025. g. 29. aug. 18:36 UTC

Peļņas

These Were the Best & Worst S&P 500 Stocks in August -- Barrons.com

2025. g. 29. aug. 18:26 UTC

Peļņas

What the Stock Market Learned About Earnings and Consumers This Summer -- Barrons.com

2025. g. 29. aug. 17:48 UTC

Tirgus saruna

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

2025. g. 29. aug. 17:10 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Regulator Firing Clears Path for Union Pacific-Norfolk Southern Deal -- Market Talk

2025. g. 29. aug. 16:57 UTC

Peļņas

These Stocks Are Moving the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

2025. g. 29. aug. 16:30 UTC

Iegādes, apvienošanās, pārņemšana

Celsius Stock Is Spiking After PepsiCo Increases Stake -- Barrons.com

2025. g. 29. aug. 16:28 UTC

Iegādes, apvienošanās, pārņemšana

BBVA: Adjustment Intended to Maintain Equivalent Economic Terms of Offer Following Dividend Payments by Sabadell

2025. g. 29. aug. 16:27 UTC

Iegādes, apvienošanās, pārņemšana

BBVA: Adjustment Outlined in Announcement on May 9, 2024

2025. g. 29. aug. 16:26 UTC

Iegādes, apvienošanās, pārņemšana

BBVA Now Offering 1 Newly Issued Ordinary BBVA Share and EUR0.70 in Cash for Every 5.5483 Ordinary Shares of Sabadell

2025. g. 29. aug. 16:25 UTC

Iegādes, apvienošanās, pārņemšana

BBVA: Adjustment Factors in Interim Dividend Paid by Sabadell to Its Shareholders

2025. g. 29. aug. 16:24 UTC

Iegādes, apvienošanās, pārņemšana

BBVA Adjusts Offer for Banco de Sabadell

2025. g. 29. aug. 16:23 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Strathcona's Power Play in MEG Energy Jeopardizes Cenovus Deal -- Market Talk

2025. g. 29. aug. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 29. aug. 16:06 UTC

Tirgus saruna

Gold Futures Gain as U.S. Inflation Data Boost Rate Cut Hopes -- Market Talk

2025. g. 29. aug. 15:12 UTC

Tirgus saruna
Peļņas

Best Buy Surprise Comp Growth Potentially Driven by Switch 2 -- Market Talk

2025. g. 29. aug. 15:09 UTC

Peļņas

Small-Cap Stocks Are Rallying Again. This Time It's Real. -- Barrons.com

2025. g. 29. aug. 15:01 UTC

Tirgus saruna

Canadian Economy Expected to Slow But Grow in 2H -- Market Talk

2025. g. 29. aug. 14:49 UTC

Peļņas

These Stocks Are Moving the Most Today: Marvell, Dell, Nvidia, Alibaba, Affirm, Autodesk, Ambarella, IREN, and More -- Barrons.com

2025. g. 29. aug. 14:49 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 29. aug. 14:49 UTC

Tirgus saruna

Canada May Avoid Contraction in 3Q, But Is Expected to Struggle -- Market Talk

2025. g. 29. aug. 14:48 UTC

Peļņas

Marvell Stock Tumbles. Why the AI Chip Player Keeps Disappointing the Market. -- Barrons.com

2025. g. 29. aug. 14:43 UTC

Tirgus saruna

Rise in Canadian Household Spending May Not Worry Central Bank -- Market Talk

Salīdzinājums

Cenas izmaiņa

Omnicell Inc Prognoze

Cenas mērķis

By TipRanks

28.11% augšup

Prognoze 12 mēnešiem

Vidējais 41.75 USD  28.11%

Augstākais 55 USD

Zemākais 32 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Omnicell Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

6 ratings

4

Pirkt

2

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

24.23 / 30.44Atbalsts un pretestība

Īstermiņā

Strong Bearish Evidence

Vidējā termiņā

Strong Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

18 / 371 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.